EQT Takes McGill Partners for $2 Billion as Insurance Broker Roll-Up Enters Nordic Phase

EQT acquired a majority stake in McGill and Partners from Warburg Pincus for $2 billion, marking the second large-scale insurance broker exit in three months. Warburg exits after McGill's 2021 spinout from Marsh McLennan, where the broker had built specialty lines exposure across reinsurance, cyber, and political risk. The deal values McGill at roughly 12x forward EBITDA, a multiple consistent with Marsh's own 11.8x trailing valuation but compressed against broker peers trading near 15x in public markets. EQT's entry through its EQT X fund positions the Swedish firm alongside KKR, which reportedly monetized a $17 billion stake in USI Insurance Services in January. The pattern is consolidation velocity, not sectoral novelty.

The insurance brokerage roll-up trades on a structural thesis: fragmented regional brokers generate 18-22% EBITDA margins but lack capital to buy adjacencies or upgrade tech stacks. Private equity compressed that fragmentation by 40% over the past decade, assembling platforms like USI, Baldwin, and Hub International through serial tuck-ins averaging 6-9x EBITDA for sub-scale targets. McGill's London domicile and specialty focus—65% of revenue from reinsurance and complex commercial lines—differentiates it from the SME-focused US roll-ups. EQT now controls a broker with direct Lloyd's access and embedded relationships in catastrophe reinsurance markets where capacity tightened 30% year-over-year following $140 billion in global nat-cat losses. That market dislocation lifts broker commissions 200-400 basis points when clients scramble for scarce coverage. Warburg timed the exit to capture that cyclical lift before reinsurance rates normalize in late 2026.

The adjacency thesis runs through technology and cross-border bundling. Michael Dell's family office is simultaneously bidding $7.7 billion for Baldwin Insurance Group, a US mid-market broker with $1.2 billion in revenue. That deal—if closed—would mark the first time a tech-focused family office outbid traditional PE on a broker platform. The rationale centers on data: brokers hold decades of claims experience and policy pricing history that train underwriting models and fraud detection algorithms. EQT's playbook includes bolt-on SaaS acquisitions to digitize placement workflows, a move Aon and Marsh executed internally but smaller brokers cannot afford. McGill's specialty book becomes a testing ground for parametric product distribution and automated reinsurance treaty structuring. The $2 billion entry price buys access to $450 million in annual revenue and a broker network spanning 15 jurisdictions, but the arbitrage lies in applying EQT's northern European operational rigor to a London partnership culture. Warburg attempted similar integration but lacked the exits density EQT enjoys across Scandinavia and Germany.

Watch for McGill tuck-ins in cyber and political risk by Q3 2025, where broker margin expansion runs 600 basis points above property lines. EQT will likely add 3-5 sub-$200 million revenue brokers in jurisdictions where McGill lacks mass—Dubai, Singapore, São Paulo. The fund's €22 billion EQT X vehicle closed in 2022 and has deployed 43% of committed capital, leaving runway for follow-on acquisitions without needing a refinancing event before 2027. KKR's USI exit establishes a monetization ceiling; if KKR achieved 2.8x gross multiple on a $6 billion basis over seven years, EQT's underwriting assumes a similar hold period and comparable IRR in the low-20s range. That math works only if McGill sustains 12% organic growth, which requires either global expansion or vertical deepening into parametric and cyber.

The Michael Dell family office bid for Baldwin disrupts the LP conversation. If a tech-balance-sheet buyer outbids Blackstone or Apollo on a core financial services asset, it signals private equity's cost-of-capital advantage is narrowing. EQT structured McGill as a control stake, not a buyout, preserving management equity and avoiding the governance friction Warburg faced post-spinout. That structure also delays the exit clock—EQT can hold through 2030 without LP pressure if insurance hard-market dynamics extend another cycle. The firm's simultaneous MedTech concentration, deploying $4.3 billion across 12 deals in the past 18 months, suggests portfolio construction around inflation-resistant, recurring-revenue models. Insurance brokerage fits that mandate. The risk is multiple compression if interest rates hold above 4.5% through 2026, collapsing broker valuations back toward 9-10x EBITDA and erasing the arbitrage EQT paid to enter. Warburg chose certainty. EQT is pricing in extension.